Announcement of Financial Results
Butterfly Network, Inc. (NYSE: BFLY), a pioneering digital health company known for its innovative handheld ultrasound technology, is set to report its financial results for the third quarter of 2025 on October 31, 2025. The announcement will occur before the opening of the market, providing investors and stakeholders with early insights into the company’s performance during this period.
Leading the discussion will be Joseph DeVivo, who serves as the President, Chief Executive Officer, and Chairman of the Board, alongside Megan Carlson, the Interim Chief Financial Officer. They will host a conference call and webcast at 8:00 AM ET on the same day. This event will focus on the company’s operational advancements and financial results, allowing participants to gain a deeper understanding of the company’s trajectory.
How to Access the Conference Call
The conference call will be available in a listen-only format through a live webcast on the Butterfly Network Investor Relations website, particularly in the Events & Presentations section. For those wishing to join via telephone, it is advised to dial in approximately ten minutes before the scheduled start. Participants in the United States can connect using the toll-free number +1 833-470-1428 or the local number +1 646-844-6383. A comprehensive list of global dial-in numbers is also accessible through a dedicated link provided by the company.
Post-event, the conference call will be archived on the Investor Relations page for those unable to attend live. Additionally, a replay will be available via telephone until November 7, 2025, with specific access codes for listeners in the United States.
About Butterfly Network
Butterfly Network, Inc. is at the forefront of transforming medical imaging through its unique Ultrasound-on-Chip™ technology, which integrates advanced ultrasound capabilities with user-friendly software. The company made a significant impact in 2018 with the introduction of the Butterfly iQ, the first-ever handheld, single-probe, whole-body ultrasound system. Subsequent models, including the iQ+ and the latest iQ3, have followed, each iteration enhancing functionality and processing capabilities, reflecting the principles of Moore’s Law.
The iQ3 was recognized as the Best Medical Technology at the 2024 Prix Galien USA Awards, underscoring its significant contributions to healthcare innovation. Additionally, Butterfly Network has received accolades from various reputable sources, including Fierce 50, TIME, and Fast Company, highlighting its commitment to creating accessible imaging solutions.
With its cloud-based approach, Butterfly Network aims to democratize healthcare, addressing pressing global challenges by providing affordable and accessible imaging solutions. Its devices are already in use among healthcare professionals across multiple regions, including North America, Europe, Asia, and parts of Africa and South America. For more information on its Global Health Program, interested parties can visit the official Butterfly Network website.
Related
